3,449.30
+0.85%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Sanofi Consumer Healthcare India
Its shares trade on NSE under the ticker SANOFICONR.NS. It has been listed since 13 September 2024. In the fiscal year to 31 December 2025, it reported revenue of ₹8.78bn and net income of ₹2.40bn. At that date it held total assets of ₹5.47bn and shareholders' equity of ₹3.84bn.
Sanofi Consumer Healthcare India Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2024-09-13. Sanofi Consumer Healthcare India Limited is an India-based company. The company is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 13 Sept 2024
Leadership
Pay as last reported
- Mr. Amit JainIndependent Chairman of the Board, since 2024₹3.5m
- Ms. Maithilee MistryChief Financial Officer, Whole-Time Director, since 2025
- Mr. Nikunjkumar SavaliyaCompliance Officer, Company Secretary
- Mr. Himanshu BakshiManaging Director, Whole-Time Director, since 2024₹18.3m
- Mr. Stanislas Paul CamartNon-Executive Director
- Ms. Carol-Ann StewartNon-Executive Director
- Mr. Shobinder DuggalNon-Executive Independent Director₹2.6m
- Ms. Suparna PandhiNon-Executive Independent Director₹2.7m
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Sanofi Consumer Healthcare India Ltd manufactures consumer healthcare products in India.
- The company focuses on pain care, allergy, and digestive health segments.
- It offers a wide range of pharmaceutical products including vitamins and wellness solutions.
Weaknesses
- The company's IPO was listed on 13 September 2024.
- It operates in the competitive Indian pharmaceutical market.
- Sanofi Consumer Healthcare India Ltd is headquartered in Mumbai.
Opportunities
- India's growing healthcare market presents expansion opportunities.
- The company can leverage its product portfolio for new market segments.
- Increasing demand for wellness products in India supports growth.
Threats
- Competition from established pharmaceutical companies in India.
- Regulatory changes in the Indian healthcare sector could impact operations.
- Economic fluctuations may affect consumer spending on healthcare products.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.